Developer docs
API playgroundTry for free, no card

Search company profiles

OUI

Full company profile

uuid000fjhv

Namestring
OUI
Legal namestring
株式会社OUI
Websiteurl
ouiinc.jp
Company typeenum
Private
Founded yearint
2016
Descriptiontext

OUI Inc. is a Tokyo-based, Keio University School of Medicine spin-out founded in 2016 by practicing ophthalmologist Eisuke Shimizu (MD, PhD) to address preventable blindness in low-resource and remote settings. The company's core product is the Smart Eye Camera (SEC), a smartphone-attachment medical device that converts a smartphone camera into a portable slit-lamp microscope or ophthalmoscope, manufactured via high-precision 3D printing and requiring no battery or charging. SEC is paired with dedicated iOS applications for image capture, filing and telemedicine, and incorporates proprietary AI algorithms for nuclear cataract diagnosis (published in Scientific Reports 2023), dry eye detection, and anterior chamber depth estimation for glaucoma risk. The company also operates Mobile Eye Scan (MES), a corporate visiting eye examination service, and +Eye Dr., a remote ophthalmology image reading service.

OUI generates revenue through three streams: hardware sales of the SEC device to clinics, hospitals and individual practitioners (including via App Store distribution), corporate eye examination services delivered through partnerships such as Dai-ichi Life Insurance (effective April 2026), and recurring remote image-reading subscriptions. The company monetizes across three customer segments: corporate employers seeking presenteeism reduction, healthcare providers in underserved and rural areas (domestic and international), and international development organizations including IAPB, IDB Lab and ADB. Distribution combines direct enterprise sales, channel partnerships with insurance carriers, and international development procurement channels. Granted patents cover Japan, USA, EU, China, India, Vietnam, Malawi and ARIPO jurisdictions, and SEC is the only Japanese device in the WHO Compendium of Innovative Health Technologies for Low-Resource Settings 2024.

Short descriptiontext

OUI Inc. is a Tokyo-based medical device company that develops the Smart Eye Camera, a smartphone-attachment portable slit-lamp and ophthalmoscope with built-in AI diagnostics, serving healthcare providers in underserved regions, corporate clients via Mobile Eye Scan, and international development organizations globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTokyo, Japan
HQ citystring
Tokyo
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic medical devices, smartphone diagnostic tools, portable slit lamp, telemedicine eye care, corporate eye examinations
Industry3 codes
1Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
CodeHLAHAJACPrimaryYes
2Comprehensive Eye Exams & Vision Care
CodeHLAKAKAAPrimaryNo
3Optoelectronic Components (LEDs, photodiodes, optocouplers, optical sensors)
CodeIMAGAJAFPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Ophthalmic Goods Manufacturing339115
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Optical Instruments & Lenses3827
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Medical Devices
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Corporate Eye Examination Services (Mobile Eye Scan)
TypeProfessional Services
Description

Visiting-type corporate eye examination services offered to companies nationwide through partnerships like Dai-ichi Life. Includes eye health screenings, ophthalmologist seminars, and consultation referrals as part of corporate health management packages addressing presenteeism.

prtimes.jp
2Smart Eye Camera Device Sales
TypeHardware Sales
Description

Sale of smartphone attachment medical devices (Smart Eye Camera) to healthcare providers, clinics, hospitals, and individual practitioners. Available through App Store and direct sales.

ouiinc.jp
3Remote Reading Services (+Eye Dr.)
TypeSubscription Recurring
Description

Telemedicine reading service enabling remote ophthalmologist diagnosis using Smart Eye Camera images.

ouiinc.jp
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Corporate health examination packages offered through Dai-ichi Life partnership
ModelOtherBilling cadenceMulti-year contract
Notes

Mobile Eye Scan services provided to approximately 20 companies and 1,500+ business people to date. Services include eye health screenings, ophthalmologist seminars, and referral services as part of presenteeism countermeasures packages.

prtimes.jp
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Smart Eye Camera (SEC)
Description

Smartphone-based portable slit-lamp microscope and fundus camera for ophthalmic examinations

ouiinc.jp
+2 more records
Core offering1 text field

OUI Inc. designs, manufactures, and sells the Smart Eye Camera (SEC), a 3D-printed smartphone-attachment medical device that converts a smartphone into a portable slit-lamp microscope or ophthalmoscope for ophthalmic examinations. The company also operates Mobile Eye Scan, a corporate visiting eye examination service, and +Eye Dr., a remote ophthalmologist image-reading telemedicine service that enables eye care delivery in areas without specialist access.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Approximately 90% of examined individuals report eye-related discomfort, indicating high demand for accessible eye care
+2 more records
Product overview1 text field

OUI Inc. offers a portfolio centered on the Smart Eye Camera (SEC) — a smartphone-attachment medical device that enables ophthalmic examinations anywhere, available in slit lamp, ophthalmoscope, and veterinary models. The core SEC hardware is paired with dedicated iOS applications for image capture, filing, and telemedicine. This platform underpins two complementary services: Mobile Eye Scan, a corporate visiting eye examination service; and +Eye Dr., a remote ophthalmology image reading service that connects examinees with distant ophthalmologists.

Product and service4 records
1Smart Eye Camera (SEC) Slit Lamp Model
CategoryOphthalmic medical devices
Description

Smartphone-attachment medical device that enables anterior segment ophthalmic examination (eyelid, cornea, conjunctiva, anterior chamber, iris, lens, vitreous) equivalent to a traditional slit lamp microscope. Requires no battery or charging, fits in a doctor's coat pocket, and pairs with a dedicated iOS application for image capture, filing, and telemedicine. Targeted at ophthalmologists, non-ophthalmologist clinicians, and healthcare workers in underserved and resource-limited settings.

2Smart Eye Camera (SEC) Ophthalmoscope Model
CategoryOphthalmic medical devices
Description

Smartphone-attachment medical device that enables fundus examination by observing the optic nerve and posterior pole without requiring pupil dilation (mydriasis). Targeted at ophthalmologists and healthcare providers needing portable fundus imaging capability.

3Smart Eye Camera (SEC) Veterinary Version
CategoryVeterinary ophthalmic medical devices
Description

Animal-use medical device version of the Smart Eye Camera (SEC VET) registered as a veterinary medical device. Enables remote telemedicine consultations and allows recording of examination results as video with image reading request submission through the app. Targeted at veterinary ophthalmologists and animal healthcare providers.

4Mobile Eye Scan (MES)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

Business partnership effective April 1, 2026 to provide OUI Inc.'s Mobile Eye Scan corporate eye examination service to companies nationwide through Dai-ichi Life's sales network. The partnership aims to address presenteeism by offering eye health screenings, ophthalmologist seminars, and consultation referrals as part of Dai-ichi Life's Presenteeism Countermeasure Package.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint project with TBWA HAKUHODO for Smart Eye Camera that won Grand Prix in Innovation category and Bronze Award in Design category at Spikes Asia 2026. The collaboration focuses on branding and communication strategy for the medical device, helping to convey its social impact and innovative nature.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for Brazil indigenous community eye care project 'Aldeia em Foco' with Instituto Suel Abujamra. Project uses Smart Eye Camera and telemedicine to provide ophthalmic care to indigenous communities in Brazil. Project received IDB 2024 Innovation Award.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Brazilian partner institution for indigenous community eye care project Aldeia em Foco. Collaborates on field activities in Brazil including community screenings and telemedicine consultations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Charitable organization partnership in India for eye screening activities in Gujarat state's tribal regions. Activities include vision testing, refraction exams, and health screenings in areas with limited healthcare access.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Participation in ADB's INSPIRE Health Forum 2025 at ADB Headquarters in Manila, Philippines. OUI Inc. exhibited and participated in elevator pitch competition, winning 3rd place in Day 2 category. Forum focuses on strengthening healthcare systems and Universal Health Coverage in Asia-Pacific.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Active participation in IAPB events including Latin America Regional Meeting in Paraguay and IN SIGHT LIVE KENYA in Nairobi. IAPB is the primary global alliance for eye health, and OUI Inc. is listed in IAPB's Valued Supplier List.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Originating institution and ongoing research partner. CEO Eisuke Shimizu serves as Specially Appointed Lecturer at Keio University School of Ophthalmology. Multiple research collaborations and clinical studies conducted at Keio University Hospital.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regular participation in APAO congresses with presentations and exhibitions. Presented research at APAO 2025 in India and APAO 2026 in Hong Kong.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regular participation in ARVO annual meetings with scientific presentations and research collaborations. Presented at ARVO 2025 in Salt Lake City and ARVO 2026 in Denver.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Exhibited at EXPO 2025 Osaka-Kansai (April 29 - May 5, 2025) at Osaka Healthcare Pavilion. Over 1,500 visitors experienced the Smart Eye Camera during the exhibition.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Host of TIB PITCH GLOBAL where OUI Inc. overseas interns won 2nd place. Platform for global startups to pitch and connect with innovation ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Presented at CCOI Asia-Pacific Innovation Forum 2026 in Hong Kong on AI/Imaging Startups topic.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MOU signed with Udayana University Faculty of Medicine for joint research on Smart Eye Camera applications in Indonesia. Research paper published on interobserver reliability study.

15Mozambique Embassy in Japan
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Conducted Mobile Eye Scan examination for embassy staff and families. OUI Inc. has been collaborating with Lurio University in Mozambique since 2021 for community eye screenings.

ouiinc.jp
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with India's Aurolab (manufacturing arm of Aravind Eye System) for collaborative initiatives in eye care.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global incumbent in ophthalmic and optometric equipment (slit lamps, fundus cameras, OCT). Comparable because Topcon sells the traditional diagnostic devices that Smart Eye Camera is positioned against as a portable, lower-cost alternative.

TypeBroad incumbent
Description

Established Japanese manufacturer of ophthalmic and optometric equipment including slit lamps and fundus cameras. Directly comparable as a Japan-based maker of the traditional eye-examination devices SEC aims to supplement or replace in low-resource settings.

TypeBroad incumbent
Description

Premium global ophthalmic device maker (slit lamps, OCT, surgical microscopes). Comparable as a high-end incumbent whose installed base defines the clinical standard OUI must meet or differentiate against.

TypeDirect peer
Description

India-based maker of smartphone-based fundus cameras and AI screening tools for diabetic retinopathy and other eye diseases. Closely comparable: portable, smartphone-attached ophthalmic hardware plus AI, targeting underserved populations and tele-ophthalmology.

TypeDirect peer
Description

Finland-based maker of handheld fundus cameras and screening solutions with AI software for retinal screening. Comparable as a portable, AI-enabled eye-screening hardware+software vendor competing for similar tele-ophthalmology and primary-care customers.

TypeDirect peer
Description

Brazilian startup building smartphone-based retinal imaging devices (Eyer) with AI screening, active in Latin America. Comparable: portable smartphone ophthalmoscope + AI serving emerging markets including Brazil, where OUI also has an IDB-backed project.

TypeDirect peer
Description

India-based maker of portable, low-cost ophthalmic screening devices (3nethra series). Comparable as a portable pre-screening ophthalmic device targeting primary care and developing-country eye-health programs, similar to OUI's emerging-market use cases.

TypeDirect peer
Description

US/Italy-based developer of a smartphone ophthalmoscope attachment for retinal screening and telemedicine. Closely comparable product form factor (smartphone-attached fundus camera) and telehealth use cases.

TypeEmerging player
Description

South Korean AI health-screening company using retinal imaging for systemic disease risk prediction. Comparable through the AI-on-retinal-imaging angle that OUI's anterior-segment AI work parallels, though focused on systemic rather than ocular disease.

TypeRegional player
Description

Manufacturing arm of India's Aravind Eye Care System, producing low-cost ophthalmic devices and consumables for developing countries. Comparable mission (low-cost eye care for underserved populations); listed as an OUI partner, but also a potential peer in portable ophthalmic device manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OUI

Ophthalmic Medical Devicesouiinc.jp

OUI Inc. is a Tokyo-based medical device company that develops the Smart Eye Camera, a smartphone-attachment portable slit-lamp and ophthalmoscope with built-in AI diagnostics, serving healthcare providers in underserved regions, corporate clients via Mobile Eye Scan, and international development organizations globally.

What OUI does

OUI Inc. is a Tokyo-based, Keio University School of Medicine spin-out founded in 2016 by practicing ophthalmologist Eisuke Shimizu (MD, PhD) to address preventable blindness in low-resource and remote settings. The company's core product is the Smart Eye Camera (SEC), a smartphone-attachment medical device that converts a smartphone camera into a portable slit-lamp microscope or ophthalmoscope, manufactured via high-precision 3D printing and requiring no battery or charging. SEC is paired with dedicated iOS applications for image capture, filing and telemedicine, and incorporates proprietary AI algorithms for nuclear cataract diagnosis (published in Scientific Reports 2023), dry eye detection, and anterior chamber depth estimation for glaucoma risk. The company also operates Mobile Eye Scan (MES), a corporate visiting eye examination service, and +Eye Dr., a remote ophthalmology image reading service.

OUI generates revenue through three streams: hardware sales of the SEC device to clinics, hospitals and individual practitioners (including via App Store distribution), corporate eye examination services delivered through partnerships such as Dai-ichi Life Insurance (effective April 2026), and recurring remote image-reading subscriptions. The company monetizes across three customer segments: corporate employers seeking presenteeism reduction, healthcare providers in underserved and rural areas (domestic and international), and international development organizations including IAPB, IDB Lab and ADB. Distribution combines direct enterprise sales, channel partnerships with insurance carriers, and international development procurement channels. Granted patents cover Japan, USA, EU, China, India, Vietnam, Malawi and ARIPO jurisdictions, and SEC is the only Japanese device in the WHO Compendium of Innovative Health Technologies for Low-Resource Settings 2024.

OUI firmographics

Firmographics
Name
OUI
Legal name
株式会社OUI
Website
https://ouiinc.jp
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
OUI Inc. is a Tokyo-based medical device company that develops the Smart Eye Camera, a smartphone-attachment portable slit-lamp and ophthalmoscope with built-in AI diagnostics, serving healthcare providers in underserved regions, corporate clients via Mobile Eye Scan, and international development organizations globally.
Ownership category
akta.pro rank

OUI industry classification

Industry
Product category
Ophthalmic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Optical Instruments & Lenses (3827), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
akta.pro secondary industries
Comprehensive Eye Exams & Vision Care (HLAKAKAA), Optoelectronic Components (LEDs, photodiodes, optocouplers, optical sensors) (IMAGAJAF)

Keywords

  • Ophthalmic medical devices
  • Smartphone diagnostic tools
  • Portable slit lamp
  • Telemedicine eye care
  • Corporate eye examinations

Where OUI is headquartered

Location

Headquarters

HQ city
Tokyo
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

OUI business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Corporate Eye Examination Services (Mobile Eye Scan): Visiting-type corporate eye examination services offered to companies nationwide through partnerships like Dai-ichi Life. Includes eye health screenings, ophthalmologist seminars, and consultation referrals as part of corporate health management packages addressing presenteeism.
  2. Smart Eye Camera Device Sales: Sale of smartphone attachment medical devices (Smart Eye Camera) to healthcare providers, clinics, hospitals, and individual practitioners. Available through App Store and direct sales.
  3. Remote Reading Services (+Eye Dr.): Telemedicine reading service enabling remote ophthalmologist diagnosis using Smart Eye Camera images.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCorporate health examination packages offered through Dai-ichi Life partnership

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

OUI product offering

Product offering

Core offering

OUI Inc. designs, manufactures, and sells the Smart Eye Camera (SEC), a 3D-printed smartphone-attachment medical device that converts a smartphone into a portable slit-lamp microscope or ophthalmoscope for ophthalmic examinations. The company also operates Mobile Eye Scan, a corporate visiting eye examination service, and +Eye Dr., a remote ophthalmologist image-reading telemedicine service that enables eye care delivery in areas without specialist access.

Product overview

OUI Inc. offers a portfolio centered on the Smart Eye Camera (SEC) — a smartphone-attachment medical device that enables ophthalmic examinations anywhere, available in slit lamp, ophthalmoscope, and veterinary models. The core SEC hardware is paired with dedicated iOS applications for image capture, filing, and telemedicine. This platform underpins two complementary services: Mobile Eye Scan, a corporate visiting eye examination service; and +Eye Dr., a remote ophthalmology image reading service that connects examinees with distant ophthalmologists.

Differentiator

Problem solved

Functional benefit

Brands

  • Smart Eye Camera (SEC): Smartphone-based portable slit-lamp microscope and fundus camera for ophthalmic examinations
  • Mobile Eye Scan (MES)
  • +Eye Dr.

Products and services

  • Smart Eye Camera (SEC) Slit Lamp Model Smartphone-attachment medical device that enables anterior segment ophthalmic examination (eyelid, cornea, conjunctiva, anterior chamber, iris, lens, vitreous) equivalent to a traditional slit lamp microscope. Requires no battery or charging, fits in a doctor's coat pocket, and pairs with a dedicated iOS application for image capture, filing, and telemedicine. Targeted at ophthalmologists, non-ophthalmologist clinicians, and healthcare workers in underserved and resource-limited settings.
  • Smart Eye Camera (SEC) Ophthalmoscope Model Smartphone-attachment medical device that enables fundus examination by observing the optic nerve and posterior pole without requiring pupil dilation (mydriasis). Targeted at ophthalmologists and healthcare providers needing portable fundus imaging capability.
  • Smart Eye Camera (SEC) Veterinary Version Animal-use medical device version of the Smart Eye Camera (SEC VET) registered as a veterinary medical device. Enables remote telemedicine consultations and allows recording of examination results as video with image reading request submission through the app. Targeted at veterinary ophthalmologists and animal healthcare providers.
  • Mobile Eye Scan (MES)

Quantifiable outcome

  • Approximately 90% of examined individuals report eye-related discomfort, indicating high demand for accessible eye care
  • +2 more outcomes

Companies that use OUI

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

OUI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

OUI partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and minor.

  • Dai-ichi Life Insurance CompanycoreChannel Partner/ Reseller/ Distributor · 1 April 2026Business partnership effective April 1, 2026 to provide OUI Inc.'s Mobile Eye Scan corporate eye examination service to companies nationwide through Dai-ichi Life's sales network. The partnership aims to address presenteeism by offering eye health screenings, ophthalmologist seminars, and consultation referrals as part of Dai-ichi Life's Presenteeism Countermeasure Package.
  • TBWA HAKUHODOcoreStrategic or Co-development PartnerJoint project with TBWA HAKUHODO for Smart Eye Camera that won Grand Prix in Innovation category and Bronze Award in Design category at Spikes Asia 2026. The collaboration focuses on branding and communication strategy for the medical device, helping to convey its social impact and innovative nature.
  • IDB Lab (Inter-American Development Bank Lab)coreStrategic or Co-development PartnerPartnership for Brazil indigenous community eye care project 'Aldeia em Foco' with Instituto Suel Abujamra. Project uses Smart Eye Camera and telemedicine to provide ophthalmic care to indigenous communities in Brazil. Project received IDB 2024 Innovation Award.
  • Instituto Suel AbujamracoreStrategic or Co-development PartnerBrazilian partner institution for indigenous community eye care project Aldeia em Foco. Collaborates on field activities in Brazil including community screenings and telemedicine consultations.
  • DivyaJyoti TrustminorStrategic or Co-development PartnerCharitable organization partnership in India for eye screening activities in Gujarat state's tribal regions. Activities include vision testing, refraction exams, and health screenings in areas with limited healthcare access.
  • Asian Development Bank (ADB)coreStrategic or Co-development PartnerParticipation in ADB's INSPIRE Health Forum 2025 at ADB Headquarters in Manila, Philippines. OUI Inc. exhibited and participated in elevator pitch competition, winning 3rd place in Day 2 category. Forum focuses on strengthening healthcare systems and Universal Health Coverage in Asia-Pacific.
  • IAPB (International Agency for Prevention of Blindness)coreStrategic or Co-development PartnerActive participation in IAPB events including Latin America Regional Meeting in Paraguay and IN SIGHT LIVE KENYA in Nairobi. IAPB is the primary global alliance for eye health, and OUI Inc. is listed in IAPB's Valued Supplier List.
  • Keio University School of MedicinecoreStrategic or Co-development PartnerOriginating institution and ongoing research partner. CEO Eisuke Shimizu serves as Specially Appointed Lecturer at Keio University School of Ophthalmology. Multiple research collaborations and clinical studies conducted at Keio University Hospital.
  • APAO (Asia-Pacific Academy of Ophthalmology)coreStrategic or Co-development PartnerRegular participation in APAO congresses with presentations and exhibitions. Presented research at APAO 2025 in India and APAO 2026 in Hong Kong.
  • ARVO (Association for Research in Vision and Ophthalmology)coreStrategic or Co-development PartnerRegular participation in ARVO annual meetings with scientific presentations and research collaborations. Presented at ARVO 2025 in Salt Lake City and ARVO 2026 in Denver.
  • EXPO 2025 Osaka-KansaicoreStrategic or Co-development PartnerExhibited at EXPO 2025 Osaka-Kansai (April 29 - May 5, 2025) at Osaka Healthcare Pavilion. Over 1,500 visitors experienced the Smart Eye Camera during the exhibition.
  • Tokyo Innovation BaseminorStrategic or Co-development PartnerHost of TIB PITCH GLOBAL where OUI Inc. overseas interns won 2nd place. Platform for global startups to pitch and connect with innovation ecosystem.
  • CCOI (Hong Kong Chamber of Commerce)minorStrategic or Co-development PartnerPresented at CCOI Asia-Pacific Innovation Forum 2026 in Hong Kong on AI/Imaging Startups topic.
  • Udayana University (Indonesia)coreStrategic or Co-development PartnerMOU signed with Udayana University Faculty of Medicine for joint research on Smart Eye Camera applications in Indonesia. Research paper published on interobserver reliability study.
  • Mozambique Embassy in JapanminorStrategic or Co-development PartnerConducted Mobile Eye Scan examination for embassy staff and families. OUI Inc. has been collaborating with Lurio University in Mozambique since 2021 for community eye screenings.
  • Aurolab (Aravind Eye System)minorStrategic or Co-development PartnerPartnership with India's Aurolab (manufacturing arm of Aravind Eye System) for collaborative initiatives in eye care.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

OUI competitors and assessment

Company assessment

Broad incumbents

  • Topcon Corporation: Global incumbent in ophthalmic and optometric equipment (slit lamps, fundus cameras, OCT). Comparable because Topcon sells the traditional diagnostic devices that Smart Eye Camera is positioned against as a portable, lower-cost alternative.
  • Nidek Co., Ltd. Established Japanese manufacturer of ophthalmic and optometric equipment including slit lamps and fundus cameras. Directly comparable as a Japan-based maker of the traditional eye-examination devices SEC aims to supplement or replace in low-resource settings.
  • Carl Zeiss Meditec: Premium global ophthalmic device maker (slit lamps, OCT, surgical microscopes). Comparable as a high-end incumbent whose installed base defines the clinical standard OUI must meet or differentiate against.

Direct peers

  • Remidio Innovative Solutions: India-based maker of smartphone-based fundus cameras and AI screening tools for diabetic retinopathy and other eye diseases. Closely comparable: portable, smartphone-attached ophthalmic hardware plus AI, targeting underserved populations and tele-ophthalmology.
  • Optomed: Finland-based maker of handheld fundus cameras and screening solutions with AI software for retinal screening. Comparable as a portable, AI-enabled eye-screening hardware+software vendor competing for similar tele-ophthalmology and primary-care customers.
  • Phelcom Technologies: Brazilian startup building smartphone-based retinal imaging devices (Eyer) with AI screening, active in Latin America. Comparable: portable smartphone ophthalmoscope + AI serving emerging markets including Brazil, where OUI also has an IDB-backed project.
  • Forus Health: India-based maker of portable, low-cost ophthalmic screening devices (3nethra series). Comparable as a portable pre-screening ophthalmic device targeting primary care and developing-country eye-health programs, similar to OUI's emerging-market use cases.
  • D-EYE: US/Italy-based developer of a smartphone ophthalmoscope attachment for retinal screening and telemedicine. Closely comparable product form factor (smartphone-attached fundus camera) and telehealth use cases.

Emerging players

  • Mediwhale: South Korean AI health-screening company using retinal imaging for systemic disease risk prediction. Comparable through the AI-on-retinal-imaging angle that OUI's anterior-segment AI work parallels, though focused on systemic rather than ocular disease.

Regional players

  • Aurolab (Aravind Eye Care System): Manufacturing arm of India's Aravind Eye Care System, producing low-cost ophthalmic devices and consumables for developing countries. Comparable mission (low-cost eye care for underserved populations); listed as an OUI partner, but also a potential peer in portable ophthalmic device manufacturing.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

OUI social profiles

Digital presence

OUI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OUI leadership team

Management profile

Number of profiles

Profiles8 records

OUI funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OUI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OUI

What does OUI do?

OUI Inc. designs, manufactures, and sells the Smart Eye Camera (SEC), a 3D-printed smartphone-attachment medical device that converts a smartphone into a portable slit-lamp microscope or ophthalmoscope for ophthalmic examinations. The company also operates Mobile Eye Scan, a corporate visiting eye examination service, and +Eye Dr., a remote ophthalmologist image-reading telemedicine service that enables eye care delivery in areas without specialist access.

Is OUI a public or private company?

OUI is a private company. It is classified as venture growth investor backed and is currently operating.

When was OUI founded?

OUI was founded in 2016. It employs 11 to 50 people.

Where is OUI based?

OUI is headquartered in Tokyo, Japan, in the Asia region.

How does OUI make money?

Three revenue lines are on record. Corporate Eye Examination Services (Mobile Eye Scan) is the primary driver. The others are smart Eye Camera Device Sales and remote Reading Services (+Eye Dr.).

Who are OUI's main competitors?

Broad incumbents on record are Topcon Corporation, Nidek Co., Ltd. and Carl Zeiss Meditec. Direct peers are Remidio Innovative Solutions, Optomed, Phelcom Technologies, Forus Health and D-EYE. Mediwhale is listed as an emerging player. Aurolab (Aravind Eye Care System) is listed as a regional player.

Does OUI have an API?

No public API is recorded for OUI.

What industry is OUI in?

OUI's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLAKAKAA, Comprehensive Eye Exams & Vision Care. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesOUI Corporation received the Minister of Education, Culture, Sports, Science and Technology Award at the 'University Venture Awards 2026'!OUI Inc. received the Minister of Education, Culture, Sports, Science and Technology Award at the 2026 University Venture Awards, announced August 27, 2026. The company's smartphone-mounted ophthalmic device SEC and telemedicine system aim to expand access to eye care in over 60 countries. It plans to accelerate R&D and platform implementation domestically and internationally.PrtimesSmart Eye Cameraが医療・ヘルスケア分野の国際賞「Clio Health 2026」で二つの金賞を受賞!OUI Inc.'s Smart Eye Camera project won two gold awards at the Clio Health Awards 2026, in the Innovation and Design categories. The project, a collaboration with TBWA HAKUHODO, aims to make eye exams accessible in remote areas. The win follows multiple prior recognitions.PrtimesSmart Eye Cameraが世界最高峰のデザイン・広告賞「D&AD Awards 2026」にてGraphite Pencil(銀賞)を受賞!Smart Eye Camera, a joint project by OUI Inc. and TBWA HAKUHODO, won the Graphite Pencil (silver) at the D&AD Awards 2026 in London. The award recognizes the product design's high level, following multiple prior recognitions. The device enables eye exams in areas without electricity.PrtimesSmart Eye Cameraが世界三大広告賞「THE ONE SHOW2026」で銅賞含む4部門受賞!Smart Eye Camera, a joint project by OUI Inc. and TBWA HAKUHODO, won four awards at The One Show 2026, including a bronze in IP & Product Design. The device, developed by OUI Inc., is an iPhone attachment for eye exams in areas without electricity.PrtimesSmart Eye Cameraが世界三大広告賞「2026 Clio Awards」で銅賞を受賞Smart Eye Camera, a joint project by OUI Inc. and TBWA HAKUHODO, won a bronze award in the Digital/Mobile Emerging Technology category at the 2026 Clio Awards. The project has also received multiple prior recognitions, including a Cannes Lions finalist spot and a Mad Stars gold award.PrtimesOUI Inc. and Dai-ichi Life have started a business partnership to support corporate health management.OUI Inc., a venture company originating from Keio University School of Medicine, has entered a business partnership with Dai-ichi Life Insurance Company, effective April 1, 2026, to provide OUI Inc.'s corporate visit-type eye examination service 'Mobile Eye Scan' to companies nationwide through Dai-ichi Life's sales network. The partnership aims to address presenteeism—productivity loss from employees working while experiencing physical discomfort—by offering eye health screenings, seminars by ophthalmologists, and consultation referrals as part of Dai-ichi Life's Presenteeism Countermeasure Package. To date, OUI Inc. has delivered Mobile Eye Scan examinations to approximately 20 companies and over 1,500 business people, with about 90% of examinees reporting eye-related discomfort.